NCCN Guidelines for Patients® | Prostate Cancer - page 83

NCCN Guidelines for Patients
: Prostate Cancer
Version 1.2014
Part 9: Dictionary
Par t 1
Par t 2
Par t 3
Par t 4
Par t 5
Par t 6
Par t 7
Par t 8
Par t 9
Pelvic lymph node dissection (PLND)
Removal of the lymph nodes
in the pelvis.
The area in men between the scrotum
and anus.
Persistent cancer
Cancer not completely removed
or destroyed by treatment.
Primary grade
The most common pattern of prostate
cells’ ability to form into glands.
Primary treatment
The main treatment used to cure
or control cancer.
A prediction of the pattern and
outcome of a disease based on
clinical information.
A male gland that makes fluid for
protecting sperm from acid in the
Prostate-specific antigen (PSA)
A protein made by the prostate.
Prostate-specific antigen (PSA)
Comparison of the level of PSA
to the size of the prostate.
Prostate-specific antigen (PSA)
doubling time
The time during which the level
of PSA doubles.
Prostate-specific antigen (PSA)
Number of nanograms per milliliter
of PSA.
Prostate-specific antigen (PSA)
How much the level of PSA changes
over time.
Radiation oncologist
A doctor who specializes in the
treatment of cancer with radiation.
Radical perineal prostatectomy
Removal of the prostate through
the perineum.
Radical retropubic prostatectomy
Removal of the prostate through one
incision in the lower abdomen.
A doctor who specializes in
reading imaging tests.
A drug that contains a
radioactive substance.
The return of cancer after a
disease-free period.
Risk group
Prediction of a person’s chances
for an event based on if he or she
matches the criteria of a group.
Robotic-assisted prostatectomy
A laparoscopic prostatectomy during
which a surgeon uses a machine
to operate.
Salvage therapy
The treatment given after standard
treatment fails.
Secondary grade
The second most common pattern
of prostate cells’ ability to form
into glands.
1...,73,74,75,76,77,78,79,80,81,82 84,85,86,87,88,89,90,91,92
Powered by FlippingBook